For the treatment of esophageal variceal bleeding in patients with cirrhotic liver disease and has also shown efficacy in the treatment of patients with AIDS-related diarrhea.

For the intravenous treatment of patients with acutely decompensated congestive heart failure who have dyspnea at rest or with minimal activity.

Indicated as an adjuvant for influenza vaccine in elderly patients and as an adjuvant for both influenza and hepatitis B vaccines in chronic hemodialysis patients who failed to ...

Investigated for use/treatment in lymphoma (non-hodgkin's), psoriasis and psoriatic disorders, bone metastases, multiple myeloma, prostate cancer, and rheumatoid arthritis.

For the treatment of serious bacterial infections in hospitalised patients.

Investigated for use/treatment in onychomycosis.

Defibrotide is used to treat or prevent a failure of normal blood flow (occlusive venous disease, OVD) in the liver of patients who have had bone marrow transplants or received ...

For the symptomatic treatment of non-infectious diarrhea in adult patients with HIV/AIDS who are taking antiretroviral therapy.

Investigated for use/treatment in leukemia (lymphoid), lymphoma (non-hodgkin's), and systemic lupus erythematosus.

Investigated for use/treatment in lymphoma (non-hodgkin's).

Intended for the acute treatment of social phobia.

Investigated for use/treatment in bone marrow transplant and graft versus host disease.

For the treatment of late stage Hormone Refractory Prostate Cancer (HRPC) for which no effective therapy currently exists.

For the production of immunity to Salmonella typhi, the cause of typhoid fever.

For treatment in patients with diabetes who have clinically significant proteinuria.

Investigated for use/treatment in leukemia (lymphoid) and solid tumors.

Investigated for use/treatment in leukemia (unspecified), lymphoma (unspecified), myelodysplastic syndrome, and solid tumors.

April 18 2007 Cortex Pharmaceuticals submitted two large data packages to the FDA regarding CX717. One data set went to the FDA's Division of Neurology Drug Products for the ...

Investigated for use/treatment in hormone replacement therapy: menopause and menopause.

For the treatment of onychomycosis, a fungal infection of the nail and nail bed.